Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -5.66% |
|
-.--% | -.--% |
Valuation
Fiscal Period: August | 2022 |
---|---|
Capitalization 1 | 4.09 |
Enterprise Value (EV) 1 | 4.09 |
P/E ratio | -290 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | -291,749,893 x |
EV / FCF | - |
FCF Yield | - |
Price to Book | - |
Nbr of stocks (in thousands) | 3,895 |
Reference price 2 | 1.050 |
Announcement Date | 14/12/22 |
Income Statement Evolution (Annual data)
Fiscal Period: August | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales | - | 0.004 | 0.004 | - |
EBITDA | - | -0.005229 | -0.0294 | -0.014 |
EBIT 1 | -0.001067 | -0.005332 | -0.0295 | -0.0141 |
Operating Margin | - | -133.3% | -737.58% | - |
Earnings before Tax (EBT) 1 | -0.001067 | -0.005332 | -0.0295 | -0.0141 |
Net income 1 | -0.001067 | -0.005332 | -0.0295 | -0.0141 |
Net margin | - | -133.3% | -737.58% | - |
EPS | - | -0.001746 | -0.007574 | -0.003623 |
Free Cash Flow | - | -0.007036 | -0.0152 | - |
FCF margin | - | -175.9% | -380.02% | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 09/10/19 | 06/10/20 | 22/11/21 | 14/12/22 |
Balance Sheet Analysis
Fiscal Period: August | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net Debt 1 | - | - | 0.01 | - |
Net Cash position 1 | 0 | 0.02 | - | - |
Leverage (Debt/EBITDA) | - | - | -0.2187 x | - |
Free Cash Flow | - | -0.01 | -0.02 | - |
ROE (net income / shareholders' equity) | - | -41.7% | -336% | 473% |
ROA (Net income/ Total Assets) | - | -18.3% | -95.8% | -246% |
Assets 1 | - | 0.0291 | 0.0308 | 0.005726 |
Book Value Per Share 2 | 0 | 0.0100 | -0 | - |
Cash Flow per Share 2 | 0 | 0.0100 | 0 | - |
Capex | - | 0.01 | - | - |
Capex / Sales | - | 128.47% | - | - |
Announcement Date | 09/10/19 | 06/10/20 | 22/11/21 | 14/12/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.9M | |
+12.46% | 135B | |
+34.27% | 31.48B | |
-15.86% | 16.92B | |
+71.46% | 8.79B | |
+10.53% | 4.61B | |
-3.49% | 2.89B | |
-17.51% | 2.47B | |
+20.03% | 2.3B | |
0.00% | 2.02B |
- Stock Market
- Equities
- LQLY Stock
- Financials QLY Biotech Group Corp.